-
The Safety of 3-BROMO-6-CHLOROPYRIDAZINE
Time of Update: 2023-05-08
BCP is a toxic and hazardous chemical, and it is important to take appropriate safety measures to protect workers and the environment when handling it.
BCP is a toxic and hazardous chemical, and it is important to take appropriate safety measures to protect workers and the environment when handling it.
-
Diabetic patients often ask about the list of clean drugs, how should doctors choose
Time of Update: 2023-01-01
Come to the "doctor's station" and take a look 👇 Among them, on February 2, 2021, the National Medical Products Administration (NMPA)officially approved the indication of dapagliflozin for the treatment of heart failure with reduced ejection fraction.
-
What is the cause of progressive limb weakness and muscle atrophy for 10 years
Time of Update: 2022-09-15
▌ Localization diagnosis: patients have progressive limb and facial muscle weakness, with muscle atrophy, mild elevation of muscle enzymes, electromyography and muscular pathology suggest muscle-induced damage, which can be localized as a disease of the skeletal muscle system.
-
New endocrine therapy options for patients with prostate cancer and medical complications
Time of Update: 2021-11-15
2. In May 2021, PSA gradually increased, PSMA suggested that more than two metastases appeared, and the patient was diagnosed to enter the stage of castration-resistant prostate cancer (CRPC), and switched to enzalutamide treatment .
-
The market demand cannot hold up to 84 PD-1/L1 products. What will the latecomers survive
Time of Update: 2021-03-29
Sales are a key factor in testing the commercialization capabilities of pharmaceutical companies, and the market prospects of domestically produced PD-1 monoclonal antibody varieties have been further clarified.
-
New drug for chronic inflammatory demyelinative multiple neuropathy (CIDP)! FDA approves Pfizer Panzyga (injection of human immunoglobulin
Time of Update: 2021-02-27
February 16, 2021 // -- Pfizer (Pfizer) recently announced that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologics License Application (SBLA) for Panzyga (Intravenous Human Immunoglobulin, 10% Liquid Preparation) for the treatment of adult patients with chronic inflammatory demyelinative multiple neuropathy (CIDP).
-
Notice of the Office of the State Administration of Medical Security on the direct settlement of general outpatient expenses across provinces in The Beijing-Tianjin-Hebei, Yangtze River Delta
Time of Update: 2021-02-15
Notice of the Office of the State Health Insurance Administration on the Direct Settlement Of General Outpatient Expenses Across Provinces of Beijing, Tianjin, Hebei, Shanghai, Jiangsu, Zhejiang, Anhu
-
Accuracy doubt UK study questions prostate cancer screening techniques
Time of Update: 2020-12-17
British researchers have found that testing PSA levels does not accurately screen for high levels of prostate cancer, and can cause some patients with asymptomatic prostate cancer to be overtreated.
Researchers are calling for new tests to be found as soon as possible to accurately screen prostate cancer patients who need treatment.
-
Another medical representative was taken away
Time of Update: 2020-09-02
industry for kickbacks, red envelopes and other governance has been carried out, and this for the management of pharmaceutical representatives has also increased efforts, recently issued a cancer hospital in Guangzhou, "medical representatives visit the reception approval provisions" details.
-
New Open Source: Acquisition of BioVision, Capture Precision Medical Strategy Heights
Time of Update: 2018-01-13
January 11, New Open Source (300109) responded to the SFC inquiry letter, on the issue of shares to buy the United States BioVision company and raise matching funds for the program to explain furthe
-
Mobile medical app: searching for gold outside the hospital wall
Time of Update: 2013-04-27
2013-04-27 source: under the impact of the cross-border revolution of mobile health care in the field of medicine and health, Chinese entrepreneurs started their dreams from the medical health app fir
